Atlas Trials

Study of Resmetirom in Children and Adolescents With MASH

Clinical trial NCT07763015 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07763015
Sponsor
Madrigal Pharmaceuticals, Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
MASHMASH - Metabolic Dysfunction-Associated Steatohepatitis
Start date
2026-08-01
Primary completion
2029-07-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.